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The aim of this work was to design new hydrophilic matrix (HM)
systems by cross-linking Mesquite Seed Gum (MSG), a
galactomannan that occurs in the endosperm layer of the seeds of
a Brazilian tree, Prosopis juliflora DC, with two well-known
polysaccharides with the ability of retarding drug release, chitosan
and xanthan gum. This had in mind the idea of using these new
compounds in the preparation of extended-release dosage oral
forms. The first part of this study was dedicated to the evaluation
of MSG in terms of its functionality as a hydrophilic matrix (HM)
system for extended-release purposes. Next, we started the study
of water uptake profile of all polymers of interest (MSG, Xanthan
Gum and Chitosan), in the following media: water, SGF and SIF.
Following, we searched for the best cross-linking agent between
Glutharaldehyde (GA) and Hexamethylenediisocyanate (HMDI),
which turned out to be the GA. Next step we begun to prepare new
hydrophilic matrices of MSG_Chitosan and MSG_Xanthan Gum,
with different ratios, 1:1, 1:2 and 2:1. Finally, after deciding which
new HM system presented best results, by using statistics tools, we
investigated the mechanism controlling the rate release of the model
drug, from tablets made with this new matrix. As a final result we
concluded that the best combination of polysaccharides was
achieved with MSG and Xanthan Gum, with mass ratio of 1:2, using
glutharaldehyde aqueous solution as cross-linking agent. It
presented a prevalent zero order kinetics, which is a very important
feature when thinking about an extended-release oral dosage form.
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INTRODUCTION
The advantages of administering a single dose of a
specific drug that is released over an extended period of
time, instead of several doses, are well known to meet the
pharmaceutical industry and medicinal purposes. Various
drug delivery technologies have been developed to
extended-release objectives, including layered tablets,
osmotic pumps and use of hydrophilic matrices (HM).
Since their introduction, HM systems have been of great
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industrial interest due to their simple manufacture to
manufacture, low costs and good biocompatibility. Several
different hydrocolloids are often used in extended-release
formulations, such as cellulose ethers (Lapidus, Lordi,
1968), chitosan (Acartürk, 1989) scleroglucan (Alhaique et
al., 1989) guar gum (Syed et al., 1998) and MSG
(Cavalcanti et al., 1998). However, the major disadvantage
of this type of system is that usually it does not follow a
Fickian drug diffusion mechanism, producing different
release profiles (Lee, 1985), showing at the same time
results with low reproducibility (Felt et al., 1999). Among
the various approaches to achieving zero order release of
drugs, the change of cross-linking density of the polymer
(Reinhart et al., 1981) and the use of swelling-controlled
delivery systems were investigated (Lee, 1984; Shah et al.,
1991). Another very useful tool was the preparation of new
hydrophilic matrices by cross-linking (Coviello et al., 1998)
different polysaccharides in order to modulate the
characteristics of these new polymers for extended-release
purposes. The aim of this work is to investigate the drug
release mechanism of a galactomannan obtained from the
seeds of Prosopis juliflora (Mesquite Seed Gum - MSG)
and its use in the preparation of new hydrogels by cross-
linking it with other polysaccharides - chitosan and xanthan
gum - in order to optimize its extended-release behavior and
drug release kinetics.
MATERIALS AND METHODS
Materials
Theophylline (TPH), propranolol.HCl (PROP),
indomethacin (IND), salicylic acid (SA), sodium salicilate
(SS) were USP XXIV. Lactose (Carlo Erba-Italy), rice
starch (Chimisan-Italy), pregelatinized starch
(Laingnational-UK), microcrystalline cellulose, polyvinyl
pyrrolidone (PVP K-30), chitosan (medium and high
molecular weight Mr. = 400.000 and 600.000), xanthan
gum (Mr = 2.0 x106) (Fluka Chemica-Switzerland),
glutharadehyde (GA) (Acros Chem.-U.S.A.) and
hexamethylenediisocyanate (HMDI) (Aldrich Chem. -
U.S.A.) were used as supplied.
In all preparations of solutions and buffers, distilled
water was used. SGF and SIF (Simulated gastric fluid and
Simulated intestinal fluid) were prepared as indicated by
USP XXIII. Coarse Mesquite Seed Gum was purified to
appropriate form by filtration and obtained in the (40
mesh) by spray-drying (Büchi Mini Spray Drier B191);
inlet air temp. 184-185 oC, outlets air temp. 120-121 oC,
flow rate 0.6 L/h; the pump was set at a value of 20 and the
overall yield was 71%. The purified product showed a
viscosity of 3300 cps (1% (w/v) aqueous solution 25 oC at
20 rpm, RVT Brookfield viscometer), a moisture content
of 12.5% and average molecular weight of 2.0-3.0 x 106.
In this study MSG was extracted from the seeds collected
in January, March and December 1997.
Tablets preparation
Tablets weighing 250 mg (diameter 12.00 mm and
thickness 1.35 mm) were prepared by wet granulation
with ethanol: water (1:1) mixture or another suitable
binder solution from a mixture (5:3:2) of polymer-drug-
excipient. The granulating compression was done in a
Perkin-Elmer hydraulic press at a pressure equivalent to 5
KN for 5.0 min. The use of matrix solutions as binder or
tablets components solubilisation and liophylisation was
avoided to obtain more realistic conditions regarding the
extended-release tablets in industrial production. A PVP
K-30 5% w/v aqueous solution was used as binder and
lactose, rice starch and microcrystalline cellulose used as
filler, intragranuraly incorporated. The hardness of the
tablets obtained was measured with a Monsanto hardness
tester apparatus, and the value observed ranged from 6.5
to 7.0 kg/force. The weight obtained in all tablets ranged
from 250 to 252 mg.
In vitro drug release studies
The dissolution experiments were carried out
according to the USP XXIII apparatus I (basket) at 37 oC
using 900 mL of dissolution medium. At fixed time
intervals, 5.0-mL samples were collected and spectropho-
tometrically assayed, after dilution, with a Perkin-Elmer
Series 634 UV-Vis spectrophotometer at the appropriate
wavelength. The influence of surfactants on drug release
was also evaluated by adding Tween 80 1.0% (w/v) to the
dissolution medium. The release rate experiments were
carried out in triplicate.
Data analysis
The data obtained were plotted according to the
following equations that describe different release kinetics
of the drug from matrices:
Zero order: %D = a1 + b1. t (equation 1)
First Order: ln (100 - %D) = a2 - b2 . t (equation 2)
Higuchi: %D = a3 + b3 .t
1/2 (equation 3)
RRSBW distribution: ln [100/(100 - %D)] = a4 + b4 ln t
(equation 4)
where %D is the percentage of drug released, t is the time
and a1, a2, a3, a4; b1, b2, b3, b4 represent the intercepts and
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the slopes respectively. One way ANOVA was used to
evaluate the influence of different parameters on the
release of the drug from the matrix.
 Dynamic Swelling Studies
The dynamic swelling behavior of the polymers in
aqueous media of varying pH at room temperature was
studied. The dry polymer tablet (150 mg) was weighted
and immersed in the aqueous medium. After 20 min. the
tablet was removed, blotted with tissue paper and weighed
on a Mettler analytical balance. This procedure was
repeated every 20-min. until 120 min, when no further
weight gain was observed. In all cases equilibrium
swelling was calculated from the equation:
 Equation 5: % Swelling = 
(W – Wo) x 100
                                                    Wo
where W denotes the weight of the swollen tablet and Wo
denotes the weight of the dry tablet.
Erosion studies
The method used for the evaluation of erosion of
tablets containing theophylline, lactose and polymers was
very similar to that used in the dissolution studies. In this
experiment, the tablets were placed in the clean baskets
and then weighed accurately. The dissolution process was
carried out for 120 min at 150 rpm in SGF - 37 oC and the
basket containing the remains of the tablet was removed
and dried at 50 oC for 24 h. After cooling in a dissector to
room temperature, the residues were weighed accurately
and the loss, in percentage, was calculated considering the
drug release (% of theophylline release).
Preparation of cross-linked polysaccharides
Glutharadehyde cross-linking reactions
In separate experiments, 1.0 g of MSG and chitosan
were dissolved for 1.0 h, at room temperature in 150 mL
of distillated water and acetic acid solution 1.0% (v/v)
respectively. Then concentrated HCl (0.5mL) was added,
in both cases followed by the addition of 5.0, 10.0, 15.0,
20.0 and 40.0 % (v/w) (in relation to total polymer weight)
of glutharaldehyde. The reaction mixture was stirred for
48h at room temperature. The resulting viscous solution
was reacted with a 5.0% w/v aqueous solution of NaHSO3
for 2 hours, precipitated with ethanol and the resulting
product rinsed three times with an Ethanol: H2O 70:30
mixture. The cross-linked products were lyophilized to give
850 mg of dry powder of each product.
HMDI cross-linking reactions
In separate experiments, 1.0 g of MSG or chitosan
was dissolved for 1.0 h, at room temperature, in 150 mL
of distillated water or acetic acid solution 1.0% (w/v)
respectively. Followed by the addition of 5.0, 10.0, 15.0,
20.0 and 40.0% (v/w) of HMDI in each flask. The reaction
mixture was stirred for 48h at room temperature. To the
resulting viscous solution was added with 1.0 mL of
concentrated sulfuric acid and stirring for 2h. This solution
was mixed with ethanol and the product was washed three
times with an ethanol: H2O 70:30 mixture. The cross-
linked products were lyophilized to give 800 mg of dry
powder of each product.
Synthesis of cross-linked compounds
The compatibility of the components of the new
matrices was evaluated by infrared spectroscopy in the
physical mixture prepared under the same experimental
conditions adopted in the synthesis of all other cross-
linked polysaccharides, without the use of cross-linking
agents. These products were prepared starting from 1.0 g
of the polysaccharide mixture (weight ratio 1:1, 1:2 and
2:1) dissolved in 200 mL of distilled water
(MSG_Xanthan Gum reactions) or 1.0 % (v/v) acetic acid
aqueous solution/water (1:1) mixture (MSG_Chitosan
reactions) until the disappearance of all material in
suspension. After filtration of the yielded solution, an
appropriate amount of glutharadehyde was added and the
reaction medium was stirred for 48h at room temperature.
The viscous solution obtained was reacted with a 5.0% (w/
v) aqueous solution of NaHSO3 for 2h, and the yielded
products were freeze-dried after exhaustive dialysis, with
distilled water. The cross-linking reactions were done in
triplicate. All products obtained were characterized by
infrared spectroscopy (Perkin-Elmer FTIR spectrometer
Paragon 1000). The differential scanning calorimetry
(DSC) measurements were obtained in a Perkin Elmer
DSC 7 apparatus.
RESULTS AND DISCUSSION
Evaluation of the influence of excipients in MSG
tablets drug rate release
In previous studies Cavalcanti et al. (1998),
described the successful use of MSG as a Hydrophilic
Matrix System, reporting good results with insoluble and
soluble lipophilic drugs were used as model drug.
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However, a considerable burst effect was observed with
hydrophilic model drugs, indicating a probable polymer
erosion contribution to the drug release control
mechanisms. The data fit better into a RRSBW kinetics
model. Three lots of each proposed formulations (Table I)
were prepared using theophylline as model drug in view
and wanting to elucidate the excipients variations
influences of MSG as hydrophilic matrix system. As one
can observe in Figure 1, the best extended-release
behavior was obtained when pregelatinized starch was
used as filler, followed by the tablets prepared with
microcrystalline cellulose (p = 0.0013). Considering that
pregelatinized starch and lactose are soluble in water,
which does not apply to microcrystalline cellulose
(Daskolakis, 1994), it was possible to correlate the
improvement of matrix efficiency with the increase in
compaction, and not with the reduction in the solubility of
the excipient. The tablets prepared without filler
(formulation D) showed a higher theophylline amount of
release, confirming the close relation between granulation
compactability and drug retarding ability (Cavalcanti,
1998; Carstensen, 1987). A zero order drug release
kinetics was observed with all excipients used in SGF, the
best correlation being obtained from the tablets prepared
with pregelatinized starch as filler (r = 0.9942).
Evaluation of the influence of crop to crop variations
on extended-release profile of MSG tablets
Formulations containing lactose as filler, was
prepared with MSG extracted from seeds collected in
December 1997, January and March 1998, in order to
evaluate a possible influence of crop to crop variations in
the MSG extended-release profile. In all formulations, the
initial original characteristics of the material such as
particle size distribution, viscosity, water content, were
kept constant as granulation parameters and compaction
force applied in compression process. No variations from
crop to crop effects were observed in the extended-release
profile of the samples tested (Figure 2).
Investigation of drug release mechanism from MSG
matrix
For an appropriate evaluation of the drug delivery
control mechanism observed for MSG matrix, the
propranolol. HCl (lipophilic drug) and theophylline drug
release profile was evaluated using MSG tablets
containing different amounts of these drugs, with drug
release rate expressed as a function of the square root of
time (Table II). A linear trend was obtained in all the ca-
ses studied, the major correlation coefficient being
observed with the tablets with a reduced drug loading.
TABLE I - Composition of MSG tablet formulations
Ingredients (%) Formulations
A B C D
MSG 50 50 50 50
Lactose 30 _ _ _
Pregelatinized starch _ 30 _ _
Microcrystalline cellulose _ _ 30 _
TPH 20 20 20 20
FIGURE 1 - Evaluation of excipient modification influence in extended-release profile of MSG tablets, in SGF.
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These results suggest that the drug delivery and rate control
mechanism are related to the diffusion of model drug
through the gel layer.
In order to confirm the controlled diffusion
hypothesis, another drug release experiment was carried
out using model drugs that show solubility dependent on
pH (salicylic acid/sodium salicylate). The results using
SGF as dissolution medium, reported as function of time,
did not show significant differences in the dissolution
profiles of each one from the model drugs (p = 0.8615).
Thus, it was possible to conclude that the mechanism and
rate control of drug delivery from this matrix were related
to the drug diffusion through the gel layer (Figure 3).
FIGURE 2 - Evaluation of crop to crop variation influence in extended-release profile of MSG tablets, in SGF.
TABLE II - Plot of drug release amount vs. square root of
time from MSG matrix tablets
Model Drug Drug Content Correlation
(mg) Coefficient (r)
Theophylline 50 0.9956
Theophylline 15 0.9985
Propranolol.HCl 50 0.9912
Propranolol.HCl 15 0.9985
FIGURE 3 - Investigation of drug release control mechanism from MSG matrix.
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Investigation of the effect of addition of surfactant
and decrease in drug load on drug release profile
In order to exclude any possible influence of the
velocity solvent penetration and wetting influences on drug
release control, Tween 80 (1.0% w/v) was added to the
dissolution medium for the in vitro drug release studies of
tablets containing 50 mg of propranolol. HCl. No differences
were observed between drug amount release of propra-
nolol.HCl 50-mg tablets with and without addition of Tween
80 to the dissolution medium, which confirms this hypothesis
(p = 0.0732), indicating that the lipid solubility plays an
important role in drug diffusion, without any indication of
solvent penetration effect in the control of drug release.
At the same time, a decrease in the propranolol.HCl
load in the tablets, 50 to 15 mg, was investigated. No
Tween was added to the dissolution medium. The
comparison of the results obtained with those produced
with propranolol.HCl 50-mg and 15-mg tablets showed a
lower propranolol. HCl release for the tablets with low
drug content (15mg).
It was noticed that there was a lower drug release
rate from tablets with propranolol.HCl than from the ones
containing theophylline (Figure 4), and since theophylline
and propranolol.HCl have similar molecular volume (two
rings fused systems) and molecular weight (propranolol.
HCl 295 g and theophylline 180 g), probably only the
propranolol.HCl lipid solubility is responsible for the
reduction in drug release.
Evaluation of water uptake profiles of MSG, chitosan
and Xanthan Gum in water, SGF and SIF
The preparation of new cross-linking MSG
FIGURE 4 - Investigation of the effect of addition of surfactant and decrease in drug load on drug release profile.
hydrogels, was conducted with the intention of modulating
their drug extended-release profile. The choice of the new
hydrogel composition was made in order to introduce ionic
moieties in the polymer structure to increase its swelling,
searching at the same time, a suitable zero order drug
release kinetics. Therefore, the water uptake and extended-
release profile of two well-known efficient hydrophilic
matrices, chitosan and xanthan gum (Talukdar et al., 1995)
were investigated and the results obtained with these studies
were used as parameters to determine the advantages of
their adequate association with MSG. It was possible to
observe an intense reduction of water uptake of chitosan, in
SGF or SIF, indicating a great influence of ionic strength on
polysaccharide swelling. This behavior was not observed
with xanthan gum, which did not show an appreciable
reduction of water uptake despite the dissolution medium.
However, with MSG an increase of water uptake rate and
hydrogel volume were observed when an ionic medium
was used (Figure 5).
Evaluation of the model drug rate release profiles
from chitosan and xanthan gum tablets
The comparative in vitro drug release studies with
chitosan and xanthan gum tablets were carried out using
theophylline as model drug. When SGF was used as
dissolution medium, the lowest theophylline release
amount was observed with chitosan tablets, despite of
their low water uptake values. A very similar extended-
release profile was observed with MSG and xanthan gum
in this dissolution medium. The change of pH (SIF)
produced a remarkable change in behavior; a very high
theophylline release was observed in chitosan tablets and
a remarkable drug retarding ability registered to xanthan
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gum tablets (Figure 6). This apparent discrepancy in drug
release profiles observed in chitosan tablets in SGF and
SIF in comparison to the other polysaccharides used could
be attributed to drug dissolution or to a matrix erosion of
chitosan tablets, taking their low swelling into
consideration.
An intense erosion feature was detected in chitosan
tablets (59.0%) when compared to values of 25.3 and
27.7% obtained for MSG and xanthan respectively. The
drug release in SGF from tablets in the three polymers
studied could be considered linear with the time (i.e., zero
order kinetics). The major correlation coefficient was
obtained with MSG tablets, but very similar to the results
verified for chitosan and xanthan gum. When using SIF as
dissolution medium the zero order kinetic was not
observed after 60% release in all cases, but a good
correlation could be observed for xanthan gum tablets at
the first 40% release (Table III).
FIGURE 5 - Dynamic water uptake for MSG, chitosan and xanthan gum in water, SGF and SIF.
FIGURE 6 - Comparison of TPH release behavior in SGF and SIF from chitosan, MSG and xanthan gum tablets.
TABLE III - Drug release kinetics observed in Chitosan, MSG and Xanthan Gum matrices in SGF and SIF.
Polysaccharide Correlation Coefficient (r)
SGF/120 min SIF/420 min SIF/120 min
Chitosan 0.9863 0.5087 0.8317
MSG 0.9913 0.9524 0.9648
Xanthan gum 0.9812 0.9526 0.9984
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Selecting the agent for cross-linking reactions
From these results, it was possible to assume that
MSG_Chitosan or MSG_Xanthan Gum associations could
be able to produce the extended-release profile desired by
means of the complementary drug release characteristics of
these polysaccharides. It was then proposed the synthesis of
various new polysaccharides networks, using 1:1, 1:2 and
2:1 MSG_Chitosan and MSG_Xanthan gum ratios. The
first step of this activity was the investigation of the best
cross-linking agent and its ideal concentration, considering
as parameter the extended-release profile achieved with
glutaraldehyde (Gliko-kabir et al., 1998) and HMDI (Wu et
al., 1998) reactions with MSG, the initial material for all
cross-linking reactions and chitosan due it high reactivity.
The dynamic water uptake of cross-linked polysaccharides
exhibited in aqueous medium did not show significant
differences when 5, 10 and 15% w/w glutharadehyde were
used as cross-linking agent for MSG. An appreciable
reduction was obtained when the glutharaldehyde
concentration was increased to 20 and 40% w/w (Table IV).
The use of HMDI only produced a significant water uptake
reduction at 40% w/w concentration. It was possible to
detect some erosion only when 40% w/w of glutharadehyde
was used (19.0%). The reaction products of HMDI/MSG
cross-linking did not show a significant erosion reduction.
The theophylline drug release rate from glutharaldehyde
cross-linked polymers increased in all cases, but the values
noted with 5 to 15% w/w concentration were not
significantly different. At 40% and 20 % w/w a high
increase of drug release was noticed.
The effect of HMDI in theophylline drug release rate
was lower than that of glutharaldehyde. The statistical
analysis of the experiments using different HMDI
concentrations did not show significant differences in the
results (Table IV). The reaction of chitosan in acetic acid
solution with glutharaldehyde in all concentrations led to
an intense water uptake reduction and polymer erosion
resulting in a complete release of theophylline after 90
min. An intense gel formation was detected in the reaction
medium when using 40% w/v glutharadehyde concen-
tration. It was not possible to observe any sign of the
reaction when HMDI was used as cross-linking agent,
probably due to its hydrolysis in aqueous acidic medium
(Table V) (Castro et al., 1985).
From these results, it was possible to conclude that
only glutaraldehyde can be used as cross-linking agent at
5.0% (w/w) concentration, considering that no remarkable
change was noticed in the polysaccharide drug extended-
release profile. Then, the cross-linking reaction was made
with MSG_chitosan mixtures, using glutharadehyde as
cross-linking agent and 1:1, 1:2 and 2:1 polymer ratios. In
order to evaluate the compatibility of the two poly-
saccharides, the physical mixture was previously prepared.
A total disintegration of the tablets after 60 min. was noted
with the physical mixture. The increase of chitosan amount
in the mixture (1:2 ratio) did not change the polymer water
uptake profile. However, a great increase in water uptake
was obtained as consequence of the higher MSG content
(2:1 ratio) in the mixture (Table VI).
Polymeric matrices of MSG_Chitosan
The best theophylline release profile in SGF was
obtained with the MSG_Chitosan 1:1 polymer ratio,
showing lower theophylline release rate than that
observed with the tablets made with MSG, and similar to
TABLE IV - Characterization of cross-linked MSG-GA and
MSG-HMDI polymers considering their extended-release
profile
Polymer Water Erosion TPH
uptake (%) release (%),
(%) in SGF
MSG 79.45 25.30 46.63
MSG-GA5 80.07 25.00 51.99
MSG-GA10 80.82 24.80 51.55
MSG-GA15 79.55 25.00 51.98
MSG-GA20 73.68 22.50 57.93
MSG-GA40 73.45 19.00 62.91
MSG-HMD5 80.81 25.01 50.55
MSG-HMDI10 80.07 25.20 50.25
MSG-HMD15 80.06 25.4 49.93
MSG-HMDI20 80.03 25.00 50.59
MSG-HMDI40 75.98 23.00 49.88
TABLE V - Characterization of cross-linked Chitosan-GA
polymers regarding its extended-release profile
Polymer Water Erosion TPH
uptake (%) release (%),
(%) in SGF
Chitosan 61.00 59.00 48.00
Chitosan-GA5 56.00 >70 100.00
Chitosan-GA10 57.50 >70 100.00
Chitosan-GA15 56.33 >70 100.00
Chitosan-GA20 55.00 >70 100.00
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the one of tablets made with chitosan, with a good fit to zero
order drug release kinetics (r = 0.9956), more adequate
than it was observed with the isolated polymers. Using this
polymer ratio, an ideal balance between MSG and chitosan
drug retarding characteristics was obtained in SGF
dissolution medium. An increase in theophylline release
rate was observed with the increase of MSG content in the
mixture (2:1 ratio). It was possible to observe an 80%
theophylline release from the physical mixture tablets after
60 min (Figure 7). No significant difference could be
detected in the IR spectra of cross-linking polysaccharides
and the physical mixture, even though it is not the more
appropriate technique to evaluate the success of cross-
linking reactions.
However, the use of Simulated Intestinal Fluid as
dissolution medium led to an appreciable faster
theophylline release from MSG_Chitosan 1:1 matrices
(74.99% at 120 min and 95.02% at 240 min), much slower
than that obtained with chitosan (100% at 120 min), but
faster than the MSG matrix. The MSG_Chitosan 2:1
polymer ratio matrix was also tested (the larger MSG
concentration would probably be able to improve network
drug retarding ability in SIF), yielding almost invariable
results (72.30% at 120 min to 91.32 at 240 min.). It is well
known that an increase in the molecular weight of chitosan
used for extended-release purposes promotes the
increasing of its efficiency. So the substitution of the
medium molecular weight chitosan by the high molecular
weight could improve the extended-release profile of the
cross-linking polysaccharides. However, an intense
erosion and faster theophylline release were observed in
all matrices prepared with high molecular weight chitosan,
indicating that the increase of molecular weight led to a
reduction of cross-linking reactions favoring the reaction
within the chitosan chains.
MSG_Xanthan Gum matrices
The substitution of chitosan by xanthan gum in
MSG cross-linking reactions was investigated in the same
polymer ratios previously used. All products obtained
were analyzed by IR spectrometry. The spectra confirmed
that this technique is not capable of distinguish physical
mixtures from cross-linked matrices.
To effectively confirm the success of these cross-
linking reactions we made use of DSC technique. The fi-
gure 8 shows the thermograms of the physical mixture of
MSG and xanthan gum as well as those of the new blends
prepared. The physical mixtures show two endothermic
peaks at 110 oC (corresponding to the loss of the water
content of polysaccharides) and 190 oC (due to the chain
TABLE VI - Comparative evaluation of dynamic water
uptake for new cross-linked matrices
Polymer Water uptake (%)
MSG_Chitosan 1:1 64.57
MSG_Chitosan 1:2 65.08
MSG_Chitosan 2:1 76.31
Physical mixture tablet disintegration
MSG 79.45
Chitosan 61.00
FIGURE 7 - Drug release profile of MSG_Chitosan cross-linked polymers matrices, in SGF.
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relaxation and polymer molification). However, the first
peak disappeared in the case of new blends prepared and
the second peak appeared at 240 oC indicating the
formation of new polymeric entity.
The water uptake profile of the new xanthan gum
cross-linked polymers showed that the presence of
xanthan gum in the matrix led to a faster water uptake
(Figure 9). The statistical evaluation of the results showed
no significant differences between the 1:1 and 2:1
MSG_Xanthan Gum matrices water uptake behavior, as
no differences were observed in the final hydrogel volu-
me in all cases studied.
These results showed a very closer swelling
behavior for all cross-linked MSG_Xanthan Gum
matrices, indicating that the matrix swelling was not
hindered by cross-linking reaction. By comparing the
amount of theophylline release from the new
MSG_Xanthan Gum matrices and isolated polysacchari-
FIGURE 8 - DSC analysis of MSG_Xanthan Gum cross-linked products: Red – MSG_Xanthan Gum 1:2 - Brown –
MSG_Xanthan Gum 1:1 - Blue- MF (Physical mixture).
FIGURE 9 - Dynamic water uptake profile of MSG, xanthan gum and cross-linked matrices.
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des in SGF, it was possible to observe a lower drug release
from MSG_Xanthan Gum 1:1 and 1:2 polymer ratio
products than all matrices investigated. There was
difference between the drug release rate from
MSG_Xanthan Gum 2:1 polymer ratio mixtures and
xanthan gum tablets (p = 0.6197), indicating that the
increase of MSG concentration in the mixture led to a
consequent increase in drug release (Figure 10).
The best fit to zero order kinetics was observed in
the mixture with the highest MSG content (Table VII), but
a good correlation could be found in all new cross-linking
polysaccharides (better than in the isolated polymers). As
the 1:1 and 1:2 polymer ratio matrices did not show
significant differences in their theophylline drug release
rate in SGF, and the best correlation to zero order kinetics
was noted with the 1:2 polymer ratio, this could be
considered the best polymer ratio for extended-release
purposes.
However, the investigation of theophylline release
profile in SIF from 1:1 and 1:2 polymer ratio mixture
matrices showed different results from those observed in
these same matrices with the use of SGF. Similar
theophylline release rates were obtained from both
polymers mixtures at the first 120 min (p = 0.0714), but an
expressive increase in drug release was observed in the 1:2
polymer ratio mixture after this period (Figure 11). Both
matrices showed a better drug retarding ability than
xanthan gum, the best result being observed with 1:1
polymer ratio mixture. A little increase of TPH release
was also observed with 1:2 polymer ratio mixture matrix
after 380 min, which led to a final theophylline release rate
higher than that observed in xanthan gum tablets, yielding
a consequent higher total theophylline drug release rate.
From these results, it was possible to state that the MSG
matrix component was able to modulate the erosion/
swelling balance of the mixture in combination with the
xanthan gum at 1:1 and 1:2 polysaccharide ratio,
producing a new efficient extended-release matrix (Sujja-
areevath, 1998). The drug release kinetics observed in
these new matrices did not follow the zero order approach
for drug release control, but a better correlation could be
observed in both of the two new polymers in comparison
to the isolated polysaccharides in SIF for 420 min,
dissolution experiments and adequate fit until 60% drug
release (Table VIII). Considering the total theophylline
release amount in SGF and SIF, as well as the better
correlation to the zero order of its dissolution experiments
results, it was possible to conclude that the MSG_Xanthan
Gum 1:2 matrix is the best new extended-release
hydrophilic matrix.
FIGURE 10 - Comparative drug release profile evaluation of MSG, xanthan gum and cross-linked matrices in SGF.
TABLE VII - Correlation to zero order drugs release
kinetics observed for the cross-linked MSG_Xanthan Gum
matrices in SGF
Polysaccharide Correlation coefficient (r)
SGF 120 min
MSG_Xanthan Gum (1:1) 0.9858
MSG_Xanthan Gum (2:1) 0.9962
MSG_Xanthan Gum (1:2) 0.9934
MSG 0.9913
Xanthan Gum 0.9812
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Evaluation of drug delivery control mechanism
The evaluation of the drug delivery control
mechanism observed for MSG_Xanthan Gum 1:2 matrix
was done with the same experiment used for the MSG
matrix, when salicylic acid and its sodium salt were
evaluated using SGF as dissolution medium. As the drug
release amount expressed as a function of time showed the
same result in both drugs (p=0.3147), the solvent
penetration did not have any influence in drug release
control (Figure 12).
FIGURE 11 - Comparative evaluation of drug release profile for MSG, xanthan gum and cross-linked matrices, in SIF.
TABLE VIII - Correlation to zero order drugs release
kinetics observed for the cross-linked MSG_Xanthan Gum
matrices in SIF
Polysaccharide Correlation coefficient (r)
SIF 420 min
MSG_Xanthan Gum (1:1) 0.9840
MSG_Xanthan Gum (1:2) 0.9868
MSG 0.9524
Xanthan Gum 0.9526
FIGURE 12 - Drug release amount observed from salicylic acid/sodium salicylate tablets prepared with MSG_Xanthan
Gum 1:2 polymer in SGF.
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Evaluation of drug release kinetics and delivery control
mechanism from MSG_Xanthan Gum 1:2 matrix
The data of tables IX and X were plotted according
to equations 1-4. From the linear portions of the curve,
slope, intercept and correlation coefficient (r) were
calculated. The data are summarized in tables XI and XII.
With the zero order plots, the linearity was noted with
matrix 1:2 in SIF. The data yielded an apparently straight
line with zero order as well as with first order kinetics. The
correlation coefficients were high (r = 0.999). With the
Higuchi equation and the RRSBW fit, the curve showed
a straight line, but the correlation coefficients were low,
indicating lack of linear correlation between the variables.
In Simulated Gastric Fluid, the MSG_XG 1:2 matrix
presented a low value for the correlation coefficient (r =
0.997) for the zero order plot, indicating lack of linear
correlation. Linearity was noted with First Order, Higuchi
equation and RRSBW distribution. The correlation
coefficients were very high (r = 0.999).
TABLE XI - Kinetics of theophylline from MSG_XG 1:2 matrix tablets in SGF with regression analysis with all the data
of the experiment
Zero Order First Order
Slope (k) Correlation Degrees of Slope (k) Correlation Degrees of
Coefficient Freedom Coefficient Freedom
0.293 0.997 10 -0.004 -0.999 10
Higuchi Equation RRSBW Distribution
Slope (k) Correlation Degrees of Slope (k) Correlation Degrees of
Coefficient Freedom Coefficient Freedom
4.266 0.999 10 0.685 0.999 10
TABLE IX - Fractional theophylline release versus time
from a MSG_ Xanthan Gum 1:2 ratio in SGF.
Time (min) Fractional drug release (Mt/M∞)
10 0.097
20 0.143
30 0.179
40 0.209
50 0.238
60 0.271
70 0.297
80 0.322
90 0.344
100 0.369
110 0.414
120 0.431
TABLE X - Fractional theophylline release versus time from a MSG_Xanthan Gum 1:2 ratio in SIF
Time (min) Fractional drug release (Mt/M∞) Time (min) Fractional drug release (Mt/M∞)
20 0.103 240 0.584
40 0.157 260 0.680
60 0.213 280 0.701
80 0.271 300 0.735
100 0.310 320 0.754
120 0.360 340 0.766
140 0.404 360 0.792
160 0.447 380 0.809
180 0.492 400 0.822
200 0.536 420 0.848
220 0.556
C. C. S. Nogueira, L. M. Cabral, T. C. Dos Santos, A. Marucci, F. Alhaique286
By evaluating the fractional theophylline release
versus time (Figures 13 and 14), and calculating the
diffusion exponent in both media, it was possible to
conclude that the drug release control for this new
hydrophilic matrix in SIF and SGF followed an anomalous
kinetics (Table XIII).
CONCLUSIONS
It was possible to observe in this work that a
combination of distinct hydrophilic matrices through
cross-linking allows the combination of synergic
properties of MSG and xanthan gum (XG) to originate a
new entity with retarding properties and drug release
kinetics superior to those given by their isolated
constituents. A better combination was obtained with a
mixture of MSG and xanthan gum, with mass ratio of 1:2,
using 5,0% w/w glutharaldehyde aqueous solution as
cross-linking agent. Both the release profiles of
theophylline in SIF as in SGF reported more suitable with
those introduced towards isolated polysaccharides. In this
new matrix zero order kinetics is prevalent, which is ide-
al for an extended-release system. These results lead to
conclusion that this methodology will be applicable for the
preparation of other new hydrophilic matrix systems, with
TABLE XII - Kinetics of theophylline from MSG_XG 1:2 matrix tablets in SIF with regression analysis over the first
60% of drug release
Zero Order First Order
Slope (k) Correlation Degrees of Slope (k) Correlation Degrees of
Coefficient Freedom Coefficient Freedom
0.238 0.999 8 -0.004 -0.999 8
Higuchi Equation RRSBW Distribution
Slope (k) Correlation Degrees of Slope (k) Correlation Degrees of
Coefficient Freedom Coefficient Freedom
4.552 0.995 8 0.856 0.996 8
FIGURE 13 - Plot of log fractional drug release versus log t over the first 60% of drug release from a matrix containing
MSG_XG in 1:2 ratio – SGF.
TABLE XIII - Values found for diffusion exponent and
kinetic constant over the first 60% of theophilline release
from tablets containing MSG_Xanthan Gum in 1:2 ratio
Dissolution Kinetic k Exponent (n)
Medium constant
(min-n)
SGF 0.024 0.598
SIF 0.011 0.725
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better characteristics than those reported by isolated
constituents.
RESUMO
Estudo da utilização de polissacarídeos no desenvol-
vimento de formulações de liberação prolongada:
goma de semente de algaroba, goma xantana e
quitosano
O objetivo deste trabalho foi o desenvolvimento de novos
sistemas de matrizes hidrofílicas através da formação de
ligações cruzadas (cross-linking) entre a Goma da Semente
da Algaroba (GSA), uma galactomanana que ocorre no
endosperma das sementes de uma árvore nativa do Brasil,
a Prosopis juliflora DC, e dois polissacarídeos bem conhe-
cidos pela sua habilidade de retardar a liberação de
fármacos, quitosano e goma xantana, visando a utilização
das novas substâncias na preparação de formas orais de
liberação prolongada. O estudo iniciou com a avaliação da
funcionalidade GSA como matriz hidrofílica. A seguir, ini-
ciamos o estudo do perfil de absorção de água dos
polímeros envolvidos (GSA, Quitosana e goma xantana),
nos seguintes meios: água, SGF e SIF. Na etapa seguinte,
procuramos pelo melhor agente formador de ligação cru-
zada, entre os dois encontrados em literatura, glutaraldeído
(GA) e hexametilenodiisocianato (HMDI). Sendo que a GA
se apresentou como o melhor agente pelos resultados apre-
sentados. O próximo passo foi a preparação e avaliação de
novas matrizes hidrofílicas de GSA_Quitosana e
GSA_Goma Xantana, com proporções diferentes, 1:1,
1:2 e 2:1. Finalmente, após a escolha do sistema
hidrofílico que apresentou os melhores resultados, uti-
lizando as ferramentas estatísticas, investigamos o me-
canismo de controle da liberação do fármaco modelo.
Por fim concluímos que a melhor combinação de
polissacarídeos foi conseguida com a GSA e a goma
xantana, na proporção de 1:2, utilizando solução de
glutaraldeído como agente de formação de ligação cru-
zada. Esta nova matriz apresentou cinética de ordem
zero, que é fundamental em uma substância a ser utili-
zada em formulações orais sólidas de liberação prolon-
gada.
UNITERMOS: Goma de Semente de Algaroba (GSA).
Quitosano. Goma Xantana. Matrizes hidrofílicas. Rea-
ções de ligação cruzada. Formas orais de liberação pro-
longada
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